The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Immunization Safety Review: Vaccines and Autism
Walsh W, Usman A. 2001. Metallothionein Dysfunction in Children Diagnosed with Autism Spectrum Disorders. Poster: American Psychiatric Accosciation Annual Meeting, May 10, 2001. Pfeiffer Treatment Center, IL.
Waly M, Olteanu H, Banerjee R, Choi SW, Mason JB, Parker BS, Sukumar S, Shim S, Sharma A, Benzecry JM, Power-Charnitsky VA, Deth RC. 2004. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psychiatry 9(4):358-70.
Werner E, Dawson G, Munson J, Osterling J. In Press. Variation in early developmental course in autism and its relation with behavioral outcome at 3-4 years of age. J Autism Dev Disorder.
Wilson GS. 1967. The Hazards of Immunization. New York: The Athlone Press. Pp. 75-84.
Wilson K. 2004. Presentation to the Immunization Safety Review Committee. Washington, DC.
Wilson K, Mills E, Ross C, McGowan J, Jadad A. 2003. Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine: a systematic review of current epidemiological evidence. Arch Pediatr Adolesc Med 157(7):628-34.
Wing L, Potter D. 2002. The epidemiology of autistic spectrum disorders: is the prevalence rising? Mental Ret Dev Disabil Res Rev 8:151-61.
Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. 2003. Prevalence of autism in a US metropolitan area. JAMA 289(1):49-55.
Zimmerman AW. 2000. Commentary: immunological treatments for autism: in search of reasons for promising approaches. J Autism Dev Disord 30(5):481-4.
Zoghbi HY. 2003. Postnatal neurodevelopmental disorders: meeting at the synapse? Science 302(5646):826-30.